Sanoj Punnen, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    lantheus
    Date added:
    Date updated:
    11/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    telix
    Date added:
    Date updated:
    11/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Foundation One
    Date added:
    Date updated:
    11/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    ExosomeDx
    Date added:
    Date updated:
    11/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Decipher Biosciences
    Date added:
    Date updated:
    11/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Specialty Not Specified)
    Ineligible company:
    OPKO Diagnostics
    Date added:
    Date updated:
    11/12/2023
Return to Treatment for Hormone Sensitive Prostate Cancer (2023)